These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36521396)
1. Acetate circumvents impaired metabolic switch in skeletal muscle of letrozole-induced PCOS rat model by suppression of PDK4/NLRP3. Olaniyi KS; Areloegbe SE Nutrition; 2023 Mar; 107():111914. PubMed ID: 36521396 [TBL] [Abstract][Full Text] [Related]
2. Alleviation of adipose-hepatic glycolipid dysregulation by acetate in experimental PCOS model is associated with NF-κB/NLRP3 repression. Olaniyi K; Areloegbe S Can J Physiol Pharmacol; 2023 Dec; 101(12):630-641. PubMed ID: 37590975 [TBL] [Abstract][Full Text] [Related]
3. Suppression of PCSK9/NF-kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome. Olaniyi KS; Areloegbe SE Life Sci; 2022 Jul; 300():120560. PubMed ID: 35452635 [TBL] [Abstract][Full Text] [Related]
4. Acetate: A therapeutic candidate against renal disorder in a rat model of polycystic ovarian syndrome. Olaniyi KS; Areloegbe SE J Steroid Biochem Mol Biol; 2023 Jan; 225():106179. PubMed ID: 36150640 [TBL] [Abstract][Full Text] [Related]
5. Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity. Olaniyi KS; Areloegbe SE; Oyeleke MB Endocrine; 2022 Dec; 78(3):628-640. PubMed ID: 36114434 [TBL] [Abstract][Full Text] [Related]
6. Protective Role of Acetate Against Depressive-Like Behaviour Associated with Letrozole-Induced PCOS Rat Model: Involvement of HDAC2 and DNA Methylation. Wolugbom JA; Areloegbe SE; Olaniyi KS Mol Neurobiol; 2023 Jan; 60(1):355-368. PubMed ID: 36269541 [TBL] [Abstract][Full Text] [Related]
7. Fisetin mitigates letrozole-induced polycystic ovarian syndrome in rats: crosstalk of AMPK/PI3K/AKT-mediated-Nrf2 antioxidant defense mechanism and the inflammasome NLRP3/NF-κB P65/IL-1β signaling pathways. Moustafa PE; Abo El Nasr NME; Shabana ME; Saleh DO Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):8077-8088. PubMed ID: 38789632 [TBL] [Abstract][Full Text] [Related]
8. Short chain fatty acid, acetate restores ovarian function in experimentally induced PCOS rat model. Olaniyi KS; Bashir AM; Areloegbe SE; Sabinari IW; Akintayo CO; Oniyide AA; Aturamu A PLoS One; 2022; 17(7):e0272124. PubMed ID: 35881588 [TBL] [Abstract][Full Text] [Related]
9. Acetate ameliorates ovarian mitochondrial dysfunction in letrozole-induced polycystic ovarian syndrome rat model by improving mitofusin-2. Olaniyi KS; Areloegbe SE J Physiol Sci; 2024 Apr; 74(1):22. PubMed ID: 38561673 [TBL] [Abstract][Full Text] [Related]
12. Butyrate alleviates renal inflammation and fibrosis in a rat model of polycystic ovarian syndrome by suppression of SDF-1. Bashir AM; Olaniyi KS BMC Pharmacol Toxicol; 2023 Oct; 24(1):48. PubMed ID: 37789355 [TBL] [Abstract][Full Text] [Related]
13. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Højlund K Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125 [TBL] [Abstract][Full Text] [Related]
14. Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model. Areloegbe SE; Peter MU; Oyeleke MB; Olaniyi KS BMC Endocr Disord; 2022 Sep; 22(1):224. PubMed ID: 36071485 [TBL] [Abstract][Full Text] [Related]
15. Low-dose spironolactone abates cardio-renal disorder by reduction of BAX/inflammasome expression in experimentally induced polycystic ovarian syndrome rat model. Peter MU; Areloegbe SE; Akintayo CO; Oniyide AA; Aturamu A; Olaniyi KS Can J Physiol Pharmacol; 2022 Sep; 100(9):890-902. PubMed ID: 35771488 [TBL] [Abstract][Full Text] [Related]
16. Diacerein mitigates endocrine and cardio-metabolic disruptions in experimental PCOS mice model by modulating AdipoR1/ PON 1. Shah MZUH; Shrivastava VK; Muzamil S; Olaniyi KS BMC Endocr Disord; 2024 Jul; 24(1):109. PubMed ID: 38982395 [TBL] [Abstract][Full Text] [Related]
17. Acetate mitigates cardiac mitochondrial dysfunction in experimental model of polycystic ovarian syndrome by modulating GPCR41/43 and PROKR1. Areloegbe SE; Olaniyi KS Biochem Biophys Res Commun; 2023 Nov; 681():62-72. PubMed ID: 37757668 [TBL] [Abstract][Full Text] [Related]
18. Effects of Metformin on Reproductive, Endocrine, and Metabolic Characteristics of Female Offspring in a Rat Model of Letrozole-Induced Polycystic Ovarian Syndrome With Insulin Resistance. Xie Y; Xiao L; Li S Front Endocrinol (Lausanne); 2021; 12():701590. PubMed ID: 34484117 [TBL] [Abstract][Full Text] [Related]
19. Diacerein ameliorates letrozole-induced polycystic ovarian syndrome in rats. Ibrahim YF; Alorabi M; Abdelzaher WY; Toni ND; Thabet K; Hegazy A; Bahaa HA; Batiha GE; Welson NN; Morsy MA; Venugopala KN; Abdel-Aziz AM Biomed Pharmacother; 2022 May; 149():112870. PubMed ID: 35367769 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential of Selenium Nanoparticles on Letrozole-Induced Polycystic Ovarian Syndrome in Female Wistar Rats. Butt MA; Shafique HM; Mustafa M; Moghul NB; Munir A; Shamas U; Tabassum S; Kiyani MM Biol Trace Elem Res; 2023 Nov; 201(11):5213-5229. PubMed ID: 36694071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]